Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia

Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

NCT02554396 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

NCT04774237 ·Status: COMPLETED ·Phase: PHASE2

A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia

NCT02780115 ·Status: COMPLETED ·Phase: PHASE2

Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients

NCT05001243 ·Status: UNKNOWN ·Phase: PHASE1

Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia

NCT05393089 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia

NCT05270863 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma

NCT03960866 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

NCT05135286 ·Status: COMPLETED ·Phase: PHASE3

Pilocarpine, Brimonidine, Oxymetazoline (PBO) Compound to Control Presbyopia Symptoms

NCT05006911 ·Status: UNKNOWN ·Phase: PHASE1

A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

NCT03857542 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily

NCT04983589 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients

NCT06948357 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia

NCT02197806 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia

NCT03804268 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

NCT01157364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia Subjects

NCT05753189 ·Status: COMPLETED ·Phase: PHASE3

Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT05656027 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia

NCT02595528 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension

NCT01687426 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.

NCT00572455 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of a Drug Delivery System in Glaucoma

NCT01016691 ·Status: COMPLETED ·Phase: PHASE2

24-hour IOP-lowering Effect of 0.01% Bimatoprost

NCT01271686 ·Status: COMPLETED ·Phase: PHASE4

A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

NCT01594970 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329

NCT00934089 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.

NCT00595101 ·Status: COMPLETED ·Phase: PHASE2